Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug. (Q3816886): Difference between revisions
From MaRDI portal
Created a new Item |
Created claim: Wikidata QID (P12): Q33851860, #quickstatements; #temporary_batch_1712190744730 |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1073/pnas.86.9.3003 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2071990407 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q33851860 / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 03:38, 4 April 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug. |
scientific article |
Statements
Estimating the superiority of a drug to a placebo when all and only those patients at risk are treated with the drug. (English)
0 references
1989
0 references
clinical trials
0 references
estimation under biased sampling
0 references
u,v method
0 references
drug testing
0 references
